Bystander elimination of antigen loss variants in established tumors
- 22 February 2004
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 10 (3) , 294-298
- https://doi.org/10.1038/nm999
Abstract
Cancers express antigens that are targets for specific cytotoxic T lymphocytes (CTLs)1,2. However, cancer cells are genetically unstable3. Consequently, sub-populations of cancer cells that no longer express the target antigen may escape destruction by CTLs and grow progressively1,4,5,6,7,8,9,10,11,12,13. We show that cytotoxic T cells indirectly eliminate these antigen loss variants (ALVs) in a model system when the parental cancer cells express sufficient antigen to be effectively cross-presented by the tumor stroma. When the parental tumor expressed lower levels of antigen, cytotoxic T cells eradicated the antigen-positive parental cancer cells, but the ALVs escaped, grew and killed the host. By contrast, when the parental tumor expressed higher levels of antigen, cytotoxic T cells eradicated not only the parental cancer cells but also the ALVs. This 'bystander' elimination of ALVs required stromal cells expressing major histocompatibility complex (MHC) molecules capable of presenting the antigen, and occurred in tumors showing evidence of stromal destruction. ALVs were apparently eliminated indirectly when tumor-specific CTLs killed stromal cells that were cross-presenting antigen produced by and released from antigen-positive cancer cells. These results highlight the general importance of targeting the tumor stroma to prevent the escape of variant cancer cells.Keywords
This publication has 29 references indexed in Scilit:
- Death of peripheral CD8+ T cells in the absence of MHC class I is Fas-dependent and not blocked by Bcl-xLEuropean Journal of Immunology, 2003
- Natural selection of tumor variants in the generation of “tumor escape” phenotypesNature Immunology, 2002
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Cross-primed CD8+ T cells mediate graft rejection via a distinct effector pathwayNature Immunology, 2002
- Human tumor antigens recognized by T lymphocytes.The Journal of Experimental Medicine, 1996
- Primary virus-induced lymphomas evade T cell immunity by failure to express viral antigens.The Journal of Experimental Medicine, 1989
- Multiple cancers. Tumor burden permits the outgrowth of other cancers.The Journal of Experimental Medicine, 1985
- Immunoselection of tumor cell variants by mice suppressed with ultraviolet radiation.The Journal of Experimental Medicine, 1982
- The Clonal Evolution of Tumor Cell PopulationsScience, 1976